Цитирование
Zhengyu Chen, Meijie Zheng, Yuxuan Li, Xiwu Zhang, Jinjin Dou. Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact. // Cardiovascular Toxicology. – 2026. – DOI: 10.1007/s12012-026-10131-w. – URL: https://doi.org/10.1007/s12012-026-10131-w
Zhengyu Chen, Meijie Zheng, Yuxuan Li, Xiwu Zhang, & Jinjin Dou (2026). Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-026-10131-w
Zhengyu Chen, et al. “Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact.” Cardiovascular Toxicology, 2026. doi:10.1007/s12012-026-10131-w.
@article{Chen2026,
title = {Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact},
author = {Chen, Zhengyu and Zheng, Meijie and Li, Yuxuan and Zhang, Xiwu and Dou, Jinjin},
journal = {Cardiovascular Toxicology},
year = {2026},
doi = {10.1007/s12012-026-10131-w},
url = {https://doi.org/10.1007/s12012-026-10131-w}
}